Atlas Trials

Efficacy and Safety of Degarelix One Month Dosing Regimen in Korean Patients With Prostate Cancer

Clinical trial NCT01071915 · COMPLETED

Trial details

NCT number
NCT01071915
Sponsor
Ferring Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2010-03-01
Primary completion
2011-11-01
Enrollment
157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.